# A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

> **NCT01646151** · — · COMPLETED · sponsor: **Allergan** · enrollment: 2580 (actual)

## Conditions studied

- Glaucoma, Open-Angle
- Ocular Hypertension

## Interventions

- **DRUG:** Bimatoprost

## Key facts

- **NCT ID:** NCT01646151
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 2580 (ACTUAL)
- **Last updated:** 2014-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01646151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01646151, "A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01646151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*